Bress et al¹ estimated the deaths prevented and excess serious adverse events incurred if the SPRINT (Systolic Blood Pressure Intervention Trial) intensive systolic blood pressure (SBP) treatment goal were implemented in all eligible US adults and observed that, if fully implemented in eligible US adults, intensive SBP treatment could prevent ≈107 500 deaths per year; however, a consequence of this treatment strategy could be an increase in serious adverse events.

The best therapeutic target of SBP has been …

中文翻译：

---

Koh关于条款的信，“在美国采用SPRINT（收缩压干预试验）高强度血压治疗方案可避免潜在的死亡和严重不良事件：来自NHANES（国家健康和营养检查）的预测”

Bress等[ ^1]估计，如果在所有符合条件的美国成年人中实施SPRINT（收缩压干预试验）强化收缩压（SBP）治疗目标，则可以预防死亡，并引起严重的严重不良事件，并观察到，如果在符合条件的美国成年人中全面实施成人，SBP强化治疗每年可预防约107 500人死亡；然而，这种治疗策略的结果可能是严重不良事件增加。

SBP的最佳治疗目标是…